NCT02734212

Brief Summary

Veterans with PTSD report that stigma and fear of stigma have a chilling effect on their participation in mental health treatment. Despite the widely-documented effects of stigma on the recovery of individuals with mental illnesses and research demonstrating harmful consequences of internalized stigma, including decreased hope, self-esteem, personal motivation, and persistence regarding illness management, no interventions are currently available to assist Veterans with PTSD in combating the impact of internalized stigma. The goal of this research is to develop and pilot-test an intervention to provide Veterans with PTSD the skills to cope effectively with stigma and to mitigate the internalization of stigmatizing beliefs and stereotypes. To accomplish this purpose, Ending Self Stigma (ESS), an intervention composed of evidence-based methods for combating internalized stigma for serious mental illness, will be modified and tested to address issues particular to PTSD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 6, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 12, 2016

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
11 months until next milestone

Results Posted

Study results publicly available

July 24, 2017

Completed
Last Updated

September 25, 2017

Status Verified

August 1, 2017

Enrollment Period

6 months

First QC Date

April 6, 2016

Results QC Date

April 24, 2017

Last Update Submit

August 25, 2017

Conditions

Keywords

Stigmatization

Outcome Measures

Primary Outcomes (1)

  • Internalized Stigma of Mental Illness Inventory (Internalized Stigma)

    The Internalized Stigma of Mental Illness Inventory was used to measure of internalized or self-stigma. A total score is calculated by taking an average of the responses on the items (range=1 to 4). Higher total scores indicate greater internalized stigma.

    Basline and Post Treatment (~3 1/2 months)

Secondary Outcomes (2)

  • General Self-Efficacy

    Baseline and Post Treatment (~3 1/2 months)

  • Social Self-Efficacy

    Baseline and Post Treatment (~3 1/2 months)

Study Arms (2)

Ending Self-Stigma for PTSD

EXPERIMENTAL

Ending Self Stigma for PTSD (ESS-P) is a 9-session small-group (6-8 persons) course designed to help individuals with PTSD develop skills to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes. Sessions combine in-class lecture, discussion of relevance to group members' personal experiences, review and practice of strategies and skills, and group sharing, support, and problem-solving. Each session is designed to focus on a specific strategy for addressing self-stigma.

Behavioral: Ending Self Stigma for PTSD

Enhanced Treatment as Usual

OTHER

The comparison condition will consist of providing a pamphlet that discusses societal stigma and internalized stigma, and provides resources to help combat the effects of both. Participants will be given the informational pamphlet and study staff will discuss its content with the participant.

Other: Enhanced Treatment as Usual

Interventions

Ending Self Stigma for PTSD (ESS-P) is a 9-session small-group (6-8 persons) course designed to help individuals with PTSD develop skills to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes. Sessions combine in-class lecture, discussion of relevance to group members' personal experiences, review and practice of strategies and skills, and group sharing, support, and problem-solving. Each session is designed to focus on a specific strategy for addressing self-stigma.

Also known as: ESS-P
Ending Self-Stigma for PTSD

The comparison condition will consist of providing a pamphlet that discusses societal stigma and internalized stigma, and provides resources to help combat the effects of both. Participants will be given the informational pamphlet and study staff will discuss its content with the participant.

Also known as: ETAU
Enhanced Treatment as Usual

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a diagnosis of PTSD
  • age between 18 and 70
  • participation in mental health services at the VAMHCS
  • sufficient clinical stability to participate

You may not qualify if:

  • a diagnosis of serious mental illness
  • schizophrenia/schizoaffective disorder
  • bipolar disorder
  • major depression with psychotic features
  • participation in the Phase I qualitative study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, 21201, United States

Location

Related Publications (1)

  • Drapalski AL, Aakre J, Brown CH, Romero E, Lucksted A. The Ending Self-Stigma for Posttraumatic Stress Disorder (ESS-P) Program: Results of a Pilot Randomized Trial. J Trauma Stress. 2021 Feb;34(1):69-80. doi: 10.1002/jts.22593. Epub 2020 Oct 15.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticStereotyping

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersSocial BehaviorBehavior

Results Point of Contact

Title
Dr. Amy Drapalski
Organization
VISN 5 MIRECC

Study Officials

  • Amy L Drapalski, PhD

    Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessors were blind with regards to participants condition
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2016

First Posted

April 12, 2016

Study Start

November 1, 2015

Primary Completion

May 1, 2016

Study Completion

September 1, 2016

Last Updated

September 25, 2017

Results First Posted

July 24, 2017

Record last verified: 2017-08

Locations